Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR).
- Disclosed ownership: 3.9%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 3.9% ownership in X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.1% | 1,827,005 | 0 | 1,827,005 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.1% | 1,827,005 | 0 | 1,827,005 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.5% | 1,339,509 | 0 | 1,339,509 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.5% | 1,339,509 | 0 | 1,339,509 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.2% | 194,535 | 0 | 194,535 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.2% | 194,535 | 0 | 194,535 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 3.6% | 3,166,514 | 0 | 3,166,514 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 3.9% | 3,411,993 | 0 | 3,411,993 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 3.9% | 3,411,993 | 0 | 3,411,993 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 3.9% | 3,411,993 | 0 | 3,411,993 | /s/ Mark N. Lampert | Mark N. Lampert |